The impact of the patient macroenvironment on molecular subgroups in endometrial cancer
Cancer · 15.03.2026 · 132 (6)
DOI: 10.1002/cncr.70333 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer, online erschienen am 06.03.2026. Verfasst von Henrica M J Werner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Obesity. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
More than half of endometrial cancer diagnoses can be attributed to obesity. A purely molecular classification in endometrial cancer hampers further understanding of the impact of patient macroenvironment as a major risk factor. The relationship between patient factors, such as age, body mass index (BMI), comorbidity, and ethnicity, and molecular subgroups was studied in a publicly available data set ( N = 225) and two multicenter European cohorts ( N = 223; N = 946). Age at diagnosis was highest in the TP53 ‐mutated subgroup, and differed significantly between molecular subgroups. Patients with obesity were younger at diagnosis compared to their lean counterparts across all molecular subgroups (61.9 vs. 66.2 years; p < .01). Survival was worst in the TP53 ‐mutated subgroup but improved with increasing BMI, which resulted in nonsignificant differences from other subgroups when BMI was >35. These data underscore that patient factors remain important, and their integration with molecular factors needs to be better understood to ultimately improve treatment and prevention strategies in endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, the Netherlands.
- GROW-Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
- Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
- Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Obstetrics and Gynaecology, Freiburg University Hospital, Freiburg, Germany.
- Department of Pathology, University of Turku, Turku, Finland.
ORCID-Profile: Henrica M J Werner, Marike S Lombaers, Xavier Matias-Guiu
Zitieren
APA
Werner, H. M. J., van Dijk, F. A. H., Vrede, S. W., van den Bosch, A. A. S., Lombaers, M. S., Asberger, J., Huvila, J., Snijders, M., Tubita, V., Moreno, G. M., Matias-Guiu, X., Bretová, P., ENITEC Consortium, Weinberger, V., & Pijnenborg, J. M. A. (2026). The impact of the patient macroenvironment on molecular subgroups in endometrial cancer. Cancer, 132(6). https://doi.org/10.1002/cncr.70333
Vancouver
Werner HMJ, van Dijk FAH, Vrede SW, van den Bosch AAS, Lombaers MS, Asberger J, et al. The impact of the patient macroenvironment on molecular subgroups in endometrial cancer. Cancer. 2026;132(6). doi:10.1002/cncr.70333
BibTeX
@article{Werner2026,
author = {Werner, Henrica M J and van Dijk, Frederiek A H and Vrede, Stephanie W and van den Bosch, Anouk A S and Lombaers, Marike S and Asberger, Jasmin and Huvila, Jutta and Snijders, Marc and Tubita, Valeria and Moreno, Gemma Mancebo and Matias-Guiu, Xavier and Bretová, Petra and ENITEC Consortium, ENITEC Consortium and Weinberger, Vit and Pijnenborg, Johanna M A},
title = {The impact of the patient macroenvironment on molecular subgroups in endometrial cancer},
journal = {Cancer},
year = {2026},
volume = {132},
number = {6},
doi = {10.1002/cncr.70333}
}
EUVIMED